| Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery (NCT00917254) | Astellas Pharma Inc | 2009-05-01 |
| Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery (NCT00913120) | Astellas Pharma Inc | 2009-05-01 |
| YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness (NCT01028950) | Astellas Pharma Inc | 2009-05-01 |
| A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (NCT01181167) | Daiichi Sankyo Co., Ltd. | 2009-05-01 |
| Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients (NCT01140386) | Penn State University | 2009-05-01 |
| A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery (NCT00902928) | Astellas Pharma Europe B.V. | 2009-04-01 |
| Discharge ALERT: Quality Improvement Initiative (NCT00853463) | Brigham and Women's Hospital | 2009-04-01 |
| Obstructive Sleep Apnea and Venous Thromboembolism (NCT01051297) | University of Missouri-Columbia | 2009-03-01 |
| Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty (NCT00831714) | Bayer | 2009-02-01 |
| Improving Venous Thromboembolism Prophylaxis (NCT01304108) | Mayo Clinic | 2009-01-01 |
| Self-management of Anticoagulation Treatment (NCT02864537) | University of Bergen | 2009-01-01 |
| The China Pulmonary Thromboembolism Registry Study (NCT02943343) | China-Japan Friendship Hospital | 2009-01-01 |
| Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery (NCT01181141) | Daiichi Sankyo Co., Ltd. | 2008-10-01 |
| DULCIS (D-dimer and ULtrasonography in Combination Italian Study) (NCT00954395) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2008-09-01 |
| Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism (NCT00788736) | Ottawa Hospital Research Institute | 2008-09-01 |
| Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism (NCT00773448) | Ottawa Hospital Research Institute | 2008-09-01 |
| Once Weekly Subcutaneous Ports for the Administration of Anticoagulants (NCT00774748) | University of North Carolina, Chapel Hill | 2008-08-01 |
| A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (NCT01203098) | Daiichi Sankyo Co., Ltd. | 2008-07-01 |
| Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery (NCT00718224) | Sanofi | 2008-07-01 |
| Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility (NCT00714597) | Sanofi | 2008-07-01 |
| Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery (NCT00721760) | Sanofi | 2008-07-01 |
| Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (NCT00694382) | Sanofi | 2008-06-01 |
| Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery (NCT00709904) | Sanofi | 2008-06-01 |
| Frankfurt Thrombophilia Registry (NCT00683397) | Cardioangiologisches Centrum Bethanien | 2008-05-01 |
| Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery (NCT00679588) | Sanofi | 2008-04-01 |
| Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty (NCT00657150) | Boehringer Ingelheim | 2008-03-01 |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (NCT00660205) | University of Aarhus | 2008-02-01 |
| Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge (NCT00604370) | Brigham and Women's Hospital | 2008-02-01 |
| Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (NCT00571649) | Bayer | 2007-12-01 |
| Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (NCT00558259) | Boehringer Ingelheim | 2007-11-01 |
| Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement (NCT00641732) | Takeda | 2007-10-01 |
| Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing (NCT00851864) | University of Calgary | 2007-10-01 |
| Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer (NCT00476216) | University of Alabama at Birmingham | 2007-09-01 |
| The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings (NCT00830570) | Medco Health Solutions, Inc. | 2007-07-01 |
| Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients (NCT00493896) | Eastern Virginia Medical School | 2007-07-01 |
| Evaluation of Patients With Vena Cava Inferior Thrombosis (NCT00631423) | Johann Wolfgang Goethe University Hospital | 2007-07-01 |
| Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism (NCT00523614) | Center for Epidemiology and Health Research, Germany | 2007-07-01 |
| Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients (NCT00445328) | Pfizer | 2007-06-01 |
| Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis (NCT00437892) | Università degli Studi dell'Insubria | 2007-05-01 |
| D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism (NCT00428441) | Università degli Studi dell'Insubria | 2007-05-01 |
| Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) (NCT00541320) | GlaxoSmithKline | 2007-02-01 |
| Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study (NCT00439725) | Bayer | 2007-02-01 |
| Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) (NCT00634907) | Gwen McMillin | 2006-09-01 |
| Institutional Registry of Thromboembolic Disease (NCT01372514) | Hospital Italiano de Buenos Aires | 2006-08-01 |
| A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty (NCT01203072) | Daiichi Sankyo Co., Ltd. | 2006-07-01 |
| The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin (NCT00354796) | Hadassah Medical Organization | 2006-07-01 |
| Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients (NCT00814177) | Hamilton Health Sciences Corporation | 2006-07-01 |
| Toronto Thromboprophylaxis Patient Safety Initiative (NCT01869075) | Sunnybrook Health Sciences Centre | 2006-07-01 |
| Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. (NCT00362232) | Bayer | 2006-06-01 |
| Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques (NCT00755300) | University of California, Davis | 2006-06-01 |
| Dose Ranging Study in Elective Total Hip Replacement Surgery (NCT00338897) | Sanofi | 2006-05-01 |
| Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients (NCT00333021) | GlaxoSmithKline | 2006-05-01 |
| Epidemiology of Venous Thromboembolism (NCT00456196) | Brigham and Women's Hospital | 2006-04-01 |
| Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (NCT00332020) | Bayer | 2006-02-01 |
| Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. (NCT00361894) | Bayer | 2006-02-01 |
| Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin (NCT00329628) | Bayer | 2006-02-01 |
| Screening for Occult Malignancy in Idiopathic Venous Thromboembolism (NCT00361647) | University of Padova | 2006-01-01 |
| Celect Vena Cava Filter Clinical Trial (NCT00470626) | Cook Group Incorporated | 2005-11-01 |
| Odiparcil For The Prevention Of Venous Thromboembolism (NCT00244725) | GlaxoSmithKline | 2005-09-01 |
| Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE) (NCT00149357) | McMaster University | 2005-07-01 |
| Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer (NCT00981903) | University of Southern California | 2005-07-01 |
| Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma (NCT00192829) | Rambam Health Care Campus | 2005-06-01 |
| CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) (NCT00219973) | Rovi Pharmaceuticals Laboratories | 2005-05-01 |
| Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients (NCT00810784) | University of Utah | 2005-03-01 |
| Venous Thromboembolism in Pregnancy Study (NCT00856076) | Oslo University Hospital | 2005-01-01 |
| Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) (NCT00119457) | vTv Therapeutics | 2005-01-01 |
| Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis (NCT00395772) | Bayer | 2004-12-01 |
| Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (NCT00396786) | Bayer | 2004-11-01 |
| Aspirin for the Prevention of Recurrent Venous Thromboembolism (NCT00222677) | University Of Perugia | 2004-05-01 |
| An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study (NCT00402467) | Bayer | 2004-02-01 |
| The Roles of Tissue Factor in Malignant Gliomas (NCT00201903) | Ontario Clinical Oncology Group (OCOG) | 2004-01-01 |
| Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (NCT00398905) | Bayer | 2004-01-01 |
| Safety of a Diagnostic Strategy With D-Dimer Testing for PE (NCT00182221) | McMaster University | 2003-08-01 |
| Monitoring Trends in Venous Thromboembolism (NCT00063518) | University of Massachusetts, Worcester | 2003-04-01 |
| Thromboprophylaxis in Critically Ill Patients (NCT00437697) | Medical University of Vienna | 2003-04-01 |
| Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism (NCT01088334) | Slotervaart Hospital | 2002-12-01 |
| BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery (NCT01225822) | Boehringer Ingelheim | 2002-11-01 |
| Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients (NCT00135876) | Ontario Clinical Oncology Group (OCOG) | 2002-10-01 |
| Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery (NCT02170935) | Boehringer Ingelheim | 2002-04-01 |
| EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization (NCT00077753) | Sanofi | 2002-02-01 |
| Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis (NCT00689520) | Hospital Universitari de Bellvitge | 2002-01-01 |
| Computerized Registry of Patients With Venous Thromboembolism (RIETE) (NCT02832245) | Manuel Monreal | 2001-03-01 |
| Long-term Active Surveillance Study for Oral Contraceptives (LASS) (NCT00676065) | Center for Epidemiology and Health Research, Germany | 2001-02-01 |
| Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care (NCT00303407) | University Hospital, Geneva | 2001-01-01 |
| BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery (NCT02170701) | Boehringer Ingelheim | 2000-10-01 |
| Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) (NCT00007085) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-09-01 |
| Venous Thromboembolism in DM1 (NCT03141749) | Institut de Myologie, France | 2000-01-01 |
| Genetic Epidemiology of Venous Thromboembolism (NCT00005543) | Mayo Clinic | 1999-04-01 |
| Prevention of Recurrent Venous Thromboembolism (PREVENT) (NCT00000614) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Mutations, Hormone Therapy (HRT) and Venous Thromboembolism (NCT00005515) | University of Washington | 1998-09-01 |
| Fixed Dose Heparin Study (NCT00182403) | McMaster University | 1998-09-01 |
| Inflammation, Infection, and Future Cardiovascular Risk (NCT00005496) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis (NCT00005684) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-03-01 |
| Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer (NCT03660007) | Karolinska Institutet | 1992-01-01 |
| Incidence and Outcomes of Venous Thromboembolism (NCT00005351) | National Heart, Lung, and Blood Institute (NHLBI) | 1991-08-01 |
| Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization (NCT01524393) | Danderyd Hospital | 1990-01-01 |
| Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005 (NCT01176305) | Hillerod Hospital, Denmark | |
| Sleep Apnea and Tromboembolic Disease (NCT00501358) | Sociedad Española de Neumología y Cirugía Torácica | |